Lineage Cell Therapeutics
LCTX
#8743
Rank
NZ$0.20 B
Marketcap
$0.95
Share price
-1.91%
Change (1 day)
-46.72%
Change (1 year)

Lineage Cell Therapeutics (LCTX) - Total assets

Total assets on the balance sheet as of September 2024 : NZ$0.17 Billion

According to Lineage Cell Therapeutics 's latest financial reports the company's total assets are NZ$0.17 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Lineage Cell Therapeutics - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31NZ$0.15 B-17.99%
2022-12-31NZ$0.19 B-23.58%
2021-12-31NZ$0.25 B69.8%
2020-12-31NZ$0.15 B-19.31%
2019-12-31NZ$0.18 B22.79%
2018-12-31NZ$0.15 B-37.9%
2017-12-31NZ$0.24 B18.51%
2016-12-31NZ$0.20 B48.65%
2015-12-31NZ$0.13 B45.02%
2014-12-31NZ$95.48 M35.83%
2013-12-31NZ$70.29 M93.72%
2012-12-31NZ$36.28 M-38.21%
2011-12-31NZ$58.72 M-15.3%
2010-12-31NZ$69.32 M272.12%
2009-12-31NZ$18.63 M938.02%
2008-12-31NZ$1.79 M692.05%
2007-12-31NZ$0.22 M-75.46%
2006-12-31NZ$0.92 M-67.78%
2005-12-31NZ$2.86 M34.39%
2004-12-31NZ$2.13 M29.36%
2003-12-31NZ$1.64 M-42.34%
2002-12-31NZ$2.85 M-38.85%
2001-12-31NZ$4.67 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
NZ$0.53 B 212.72%๐Ÿ‡บ๐Ÿ‡ธ USA